SCHEMBL17279045

SCHEMBL17279045

C=CC(=O)OCCCCCCCCCCCOc1ccc(C(=O)Oc2ccc(COc3ccc(OCCCCCC)cc3)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.56
▸ LMNA P02545 3/20 0.56
▸ NFKB1 P19838 3/20 0.56
▸ NFKB2 Q00653 3/20 0.56
▸ RELA Q04206 3/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ CYP1A2 P05177 1/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ CYP2D6 P10635 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ THRB P10828 1/20 0.51
▸ MAPT P10636 5/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ HPGD P15428 2/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ PRSS1 P07477 1/20 0.48
▸ ACR P10323 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17279044 1.00 NPC1 (0.56) NPC1LMNANFKB1NFKB2RELA
SCHEMBL17279048 1.00 NPC1 (0.56) NPC1LMNANFKB1NFKB2RELA
SCHEMBL12963214 1.00 NPC1 (0.56) NPC1LMNANFKB1NFKB2RELA
SCHEMBL25500962 1.00 NPC1 (0.56) NPC1LMNANFKB1NFKB2RELA
SCHEMBL19497706 1.00 NPC1 (0.56) NPC1LMNANFKB1NFKB2RELA
SCHEMBL17279046 1.00 NPC1 (0.56) NPC1LMNANFKB1NFKB2RELA
SCHEMBL13089493 1.00 NPC1 (0.56) NPC1LMNANFKB1NFKB2RELA
SCHEMBL16547171 1.00 NPC1 (0.56) NPC1LMNANFKB1NFKB2RELA
SCHEMBL12963212 1.00 NPC1 (0.56) NPC1LMNANFKB1NFKB2RELA
SCHEMBL12963213 1.00 NPC1 (0.56) NPC1LMNANFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10023743-B2 Dichroic pigment compounds and compositions containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-07-17 — — US disclosed
US-10005960-B2 Composition and polarizing film SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-06-26 — — US disclosed
US-20180072890-A1 COMPOUND AND COMPOSITION CONTAINING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-03-15 — — US disclosed
US-20180030354-A1 COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-02-01 — — US disclosed
US-20170242169-A1 DICHROIC DYE COMPOUND, POLARIZING FILM, AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-08-24 — — US disclosed
US-9644148-B2 Liquid Crystal composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-09 — — US disclosed
US-20170121605-A1 COMPOSITION AND POLARIZING FILM SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-04 — — US disclosed
US-20150337203-A1 COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150337203-A1 COMPOSITION CRY1, CRY2, C5 NPC1 783/4885LMNA 465/4885NFKB1 1484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback